Literature DB >> 2002975

Aggressive therapeutic amniocentesis for treatment of twin-twin transfusion syndrome.

J P Elliott1, M A Urig, W H Clewell.   

Abstract

Acute severe twin-twin transfusion syndrome occurs in about 1% of monochorionic twin gestations. In the most severe form, acute hydramnios develops in the recipient twin's sac and fetal hydrops may be present. The donor twin is anemic and oligohydramnios is present, so that the donor appears "stuck" in a cocoon made by its adherent amnion. In this report, aggressive therapeutic amniocentesis restored amniotic fluid volume to normal in both sacs in all pregnancies. Fetal hydrops resolved in three of five (60%) of the fetuses affected. Pregnancy was extended a mean 80 +/- 33 days (+/- 2 SD) and perinatal survival was 79%. These findings contrast dramatically with the virtual 100% mortality reported in the literature with no therapy. Repeated aggressive amniocentesis effectively reversed the physiology of twin-twin transfusion syndrome and should be the treatment of choice for acute hydramnios, which previously had no recommended therapy.

Entities:  

Mesh:

Year:  1991        PMID: 2002975

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome.

Authors:  Timothy M Crombleholme; David Shera; Hanmin Lee; Mark Johnson; Mary D'Alton; Flint Porter; Jacquelyn Chyu; Richard Silver; Alfred Abuhamad; George Saade; Laurence Shields; David Kauffman; Joanne Stone; Craig T Albanese; Ray Bahado-Singh; Robert H Ball; Larissa Bilaniuk; Beverly Coleman; Diana Farmer; Vickie Feldstein; Michael R Harrison; Holly Hedrick; Jeffrey Livingston; Robert P Lorenz; David A Miller; Mary E Norton; William J Polzin; Julian N Robinson; Jack Rychik; Per L Sandberg; Istvan Seri; Erin Simon; Lynn L Simpson; Larisa Yedigarova; R Douglas Wilson; Bruce Young
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

2.  Morbidity and mortality of discordant twins up to 34 weeks of gestational age.

Authors:  J Sonntag; S Waltz; T Schollmeyer; U Schuppler; H Schroder; D Weisner
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

Review 3.  Fetal medicine.

Authors:  D James
Journal:  BMJ       Date:  1998-05-23

4.  The value of Doppler ultrasound in the diagnosis and management of twin-to-twin transfusion syndrome.

Authors:  Y Ohno; H Ando; A Tanamura; O Kurauchi; S Mizutani; Y Tomoda
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

5.  Long term outcome of twin-twin transfusion syndrome.

Authors:  R B Cincotta; P H Gray; G Phythian; Y M Rogers; F Y Chan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

6.  Twin-twin transfusion syndrome: a five year review.

Authors:  Y C Seng; V S Rajadurai
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

7.  Clinical and echographic features of in utero cardiac dysfunction in the recipient twin in twin-twin transfusion syndrome.

Authors:  N Zosmer; R Bajoria; E Weiner; M Rigby; J Vaughan; N M Fisk
Journal:  Br Heart J       Date:  1994-07

8.  Aortic and pulmonary artery calcification: An unusual manifestation of twin-to-twin transfusion syndrome.

Authors:  Sumitra Venkatesh; J Sanyukta; S Jain; S S Prabhu; S Kulkarni
Journal:  Ann Pediatr Cardiol       Date:  2017 Jan-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.